Granules India’s Hyderabad Unit Classified as ‘Official Action Indicated’ by USFDA

Granules India Ltd., a prominent pharmaceutical company, announced on Tuesday that its Hyderabad manufacturing facility has been classified as ‘Official Action Indicated’ (OAI) by the United States Food and Drug Administration (USFDA). This classification reflects compliance concerns raised by the regulatory body. What Does OAI Classification Mean? The ‘Official Action Indicated’ (OAI) classification by the … Read more